These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38239932)

  • 21. Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine Receptors.
    Jacobson KA; Suzuki F
    Drug Dev Res; 1996; 39(3-4):289-300. PubMed ID: 38239267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
    Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
    J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
    Kim YC; Ji X; Melman N; Linden J; Jacobson KA
    J Med Chem; 2000 Mar; 43(6):1165-72. PubMed ID: 10737749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
    Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
    J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
    Jiang J; van Rhee AM; Chang L; Patchornik A; Ji XD; Evans P; Melman N; Jacobson KA
    J Med Chem; 1997 Aug; 40(16):2596-608. PubMed ID: 9258367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of DPTN and other selective A
    Gao ZG; Suresh RR; Jacobson KA
    Purinergic Signal; 2021 Dec; 17(4):737-746. PubMed ID: 34713378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.
    Müller CE; Thorand M; Qurishi R; Diekmann M; Jacobson KA; Padgett WL; Daly JW
    J Med Chem; 2002 Aug; 45(16):3440-50. PubMed ID: 12139454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors.
    Brown SG; King BF; Kim YC; Jang SY; Burnstock G; Jacobson KA
    Drug Dev Res; 2000 Apr; 49(4):253-259. PubMed ID: 22791931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide P2Y
    Liston TE; Hinz S; Müller CE; Holstein DM; Wendling J; Melton RJ; Campbell M; Korinek WS; Suresh RR; Sethre-Hofstad DA; Gao ZG; Tosh DK; Jacobson KA; Lechleiter JD
    Purinergic Signal; 2020 Dec; 16(4):543-559. PubMed ID: 33129204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicinal chemistry of adenosine A3 receptor ligands.
    Müller CE
    Curr Top Med Chem; 2003; 3(4):445-62. PubMed ID: 12570761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors.
    Ohno M; Costanzi S; Kim HS; Kempeneers V; Vastmans K; Herdewijn P; Maddileti S; Gao ZG; Harden TK; Jacobson KA
    Bioorg Med Chem; 2004 Nov; 12(21):5619-30. PubMed ID: 15465340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the Role of N
    Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
    Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
    Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
    Kim YC; Ji XD; Jacobson KA
    J Med Chem; 1996 Oct; 39(21):4142-8. PubMed ID: 8863790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.